Cartia Capsule, Extended Release
Product Images NDC 71335-0879

2 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cartia (NDC 71335-0879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diltiazem Hydrochloride Chemical Structure (Image 1)

Diltiazem Hydrochloride Chemical Structure (Image 1)
Chemical structure of Diltiazem Hydrochloride showing the molecular arrangement including benzene rings, sulfur, nitrogen, and various side groups.*
FDA Label Image

Label (Lbl713350879)

Label (Lbl713350879)
Cartia XT 180 mg extended-release capsules label showing diltiazem hydrochloride as the active ingredient. The label includes the NDC 71335-0879-1, states the product is for oral use with 30 capsules per container. It is repackaged by Bryant Ranch Prepack and manufactured by Teva Pharmaceuticals USA. The label also features storage instructions, a warning to keep out of reach of children, and QR codes for more information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.